IRIS - Institutional Research Information System
IRIS è il sistema di gestione integrata dei dati della ricerca (persone, progetti, pubblicazioni, attività) adottato dall'Università degli Studi dell’Insubria.

IRInSubria - Institutional Repository Insubria
IRInSubria raccoglie, conserva, documenta e dissemina le informazioni sulla produzione scientifica dell'Università degli Studi dell’Insubria anche ai fini della valutazione della ricerca.

MARTIGNONI, EMILIA SILVANA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.423
EU - Europa 3.302
AS - Asia 596
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 6
SA - Sud America 3
Totale 9.337
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.413
IT - Italia 1.717
UA - Ucraina 614
SE - Svezia 284
TR - Turchia 241
IE - Irlanda 193
VN - Vietnam 175
FI - Finlandia 160
GB - Regno Unito 144
DE - Germania 108
CN - Cina 72
SG - Singapore 69
FR - Francia 31
IN - India 25
BE - Belgio 21
JP - Giappone 8
CA - Canada 7
EU - Europa 6
NL - Olanda 4
NZ - Nuova Zelanda 4
AU - Australia 3
ES - Italia 3
PL - Polonia 3
AE - Emirati Arabi Uniti 2
AT - Austria 2
BG - Bulgaria 2
BR - Brasile 2
DK - Danimarca 2
HR - Croazia 2
IL - Israele 2
RU - Federazione Russa 2
CH - Svizzera 1
CL - Cile 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
GL - Groenlandia 1
GR - Grecia 1
HU - Ungheria 1
IM - Isola di Man 1
LK - Sri Lanka 1
LT - Lituania 1
LU - Lussemburgo 1
MK - Macedonia 1
MX - Messico 1
NO - Norvegia 1
PK - Pakistan 1
RO - Romania 1
Totale 9.337
Salva come PNG Salva come JPEG
Città #
Milan 1.299
Fairfield 795
Chandler 587
Jacksonville 462
Woodbridge 442
Seattle 371
Ashburn 360
Houston 324
Wilmington 301
Ann Arbor 253
Cambridge 250
Dublin 192
Princeton 154
Izmir 145
Nyköping 144
Boardman 104
Dong Ket 88
Chicago 77
San Mateo 77
Como 70
Rome 69
Singapore 67
Dearborn 60
San Diego 43
Ogden 33
Dallas 32
Philadelphia 30
Norwalk 20
Brussels 19
Düsseldorf 18
Pune 16
Santa Clara 15
Edinburgh 13
Los Angeles 13
Verona 11
Kunming 9
Beijing 8
Hanoi 8
Tokyo 8
Hefei 7
Nanchang 7
Nanjing 7
Auburn Hills 6
Helsinki 6
London 6
New York 5
Fuzhou 4
Jinan 4
Munich 4
Toronto 4
Amsterdam 3
Chengdu 3
Chongqing 3
Frankfurt am Main 3
Guangzhou 3
Kocaeli 3
Madrid 3
Miami 3
Redwood City 3
Washington 3
Atlanta 2
Auckland 2
Brisbane 2
Charlotte 2
Copenhagen 2
Domodossola 2
Dubai 2
Flushing 2
Fort Worth 2
Hebei 2
Mountain View 2
Paris 2
Prusice 2
Redmond 2
Sofia 2
Stockholm 2
São Paulo 2
Tel Aviv 2
Vienna 2
Xian 2
Zagreb 2
Acton 1
Athens 1
Bengaluru 1
Berlin 1
Bucharest 1
Budapest 1
Castelnuovo Rangone 1
Catania 1
Changsha 1
Chaoyang 1
Chiswick 1
Clifton 1
Cormeilles-en-Parisis 1
Dambulla 1
Darwen 1
Douglas 1
Dromcollogher 1
Dunedin 1
Glasgow 1
Totale 7.138
Salva come PNG Salva come JPEG
Nome #
Calcium homeostasis is dysregulated in parkinsonian patients with l-DOPA-induced dyskinesias 176
5-hydroxytryptamine1B receptor and triptan response in migraine, lack of association with common polymorphisms 165
Disordered pupil reactivity in Parkinson's disease. 157
Changes of opioid modulation of the hypothalamo-pituitary-adrenal axis in patients with severe premenstrual syndrome. 156
Stimulation of corticotrophin-releasing hormone release by the obese (ob) gene product, leptin, from hypothalamic explants. 149
Neuroendocrine changes in luteal function in patients with premenstrual syndrome. 145
CARDIOVASCULAR AUTONOMIC MODULATION AND ACTIVITY OF CAROTID BARORECEPTORS AT ALTITUDE. 144
The brain as a target for adrenocortical steroids: cognitive implications. 143
The association of menstrual migraine with the premenstrual syndrome. 143
Changes of neuroendocrine axes in patients with menstrual migraine. 142
High-dose ropinirole in advanced Parkinson's disease with severe dyskinesias. 141
Cerebrospinal fluid norepinephrine, 3-methoxy-4-hydroxyphenylglycol and neuropeptide Y levels in Parkinson's disease, multiple system atrophy and dementia of the Alzheimer type. 139
Free plasma catecholamine levels in healthy subjects: a basal and dynamic study.The influence of age. 139
Autonomic regulation of heart rate and peripheral circulation: comparison of high altitude and sea level residents. 137
BDNF Val66Met polymorphism is associated with cognitive impairment in Italian patients with Parkinson's disease 137
Nocturnal sleep in multisystem atrophy with autonomic failure: polygraphic findings in ten patients. 136
Platelet catecholamines in cluster headache. 136
Peripheral markers of oxidative stress in Parkinson's disease. The role of L-DOPA. 136
Is seborrhea a sign of autonomic impairment in Parkinson's disease? 135
Changes in nociceptive flexion reflex threshold across the menstrual cycle in healthy women. 134
Monoamines and related metabolite levels in the cerebrospinal fluid of patients with dementia of Alzheimer type. Influence of treatment with L-deprenyl. 134
Effects of terguride on anterior pituitary function in parkinsonian patients treated with L-dopa: a double-blind study versus placebo. 134
Functional changes of the basal ganglia circuitry in Parkinson's disease. 133
Pituitary-adrenal responses to dexamethasone and CRH administration in patients with untreated Parkinson's disease. 133
A crossover, controlled study comparing pergolide with bromocriptine as an adjunct to levodopa for the treatment of Parkinson's disease. 132
Non-hormonal therapy of premenstrual syndrome. 132
Combined response of plasma and platelet catecholamines to different types of short-term stress. 132
Double-blind, placebo-controlled study to evaluate the efficacy and safety of botulinum toxin type A in the treatment of drooling in parkinsonism. 132
Psychometric properties of the Unified Parkinson's Disease Rating Scale and of the Short Parkinson's Evaluation Scale. 131
Effects of etoperidone on sympathetic and pituitary-adrenal responses to diverse stressors in humans. 130
Determination of hydroxyl free radical formation in human platelets using high-performance liquid chromatography with electrochemical detection. 130
"Off" painful dystonia in Parkinson's disease treated with botulinum toxin. 129
Migraine without aura and reproductive life events: a clinical epidemiological study in 1300 women. 128
Sleep attacks in Parkinson's disease: a clinical and polysomnographic study. 128
An assessment of hypothalamo-pituitary-adrenal axis functioning in non-depressed, early abstinent alcoholics. 127
Modifications of local cerebral metabolic rates for glucose and motor behavior in rats with unilateral lesion of the subthalamic nucleus. 127
The role of language areas in motor control dysfunction in Parkinson's disease. 125
Simultaneous determination of L-dopa and 3-O-methyldopa in human platelets and plasma using high-performance liquid chromatography with electrochemical detection. 125
Long-term evaluation of the effect of quetiapine on hallucinations, delusions and motor function in advanced Parkinson disease. 125
Interobserver reliability between neurologists in training of Parkinson's disease rating scales. A multicenter study. 125
A placebo-controlled evaluation of ropinirole, a novel D2 agonist, as sole dopaminergic therapy in Parkinson's disease. 125
Modifications of plasma and platelet levels of L-DOPA and its direct metabolites during treatment with tolcapone or entacapone in patients with Parkinson's disease 125
Terguride in fluctuating parkinsonian patients: a double-blind study versus placebo. 123
Drug prescribing patterns in Parkinson's disease: a pharmacoepidemiological survey in a cohort of ambulatory patients 123
Modifications of apoptosis-related protein levels in lymphocytes of patients with Parkinson’s disease. The effect of dopaminergic treatment 122
LISURIDE PLUS SELEGILINE IN THE TREATMENT OF EARLY PARKINSON'S DISEASE. 121
Naproxen sodium in menstrual migraine prophylaxis: a double-blind placebo controlled study. 121
Parkinson's disease and reproductive life events. 120
Medical healthcare use in Parkinson’s disease: survey in a cohort of ambulatory patients in Italy. 120
Changes in motoneuron excitability of masseter muscle following exteroceptive stimuli in Parkinson's disease. 118
Hashimoto's thyroiditis in association with Tolosa Hunt syndrome: a case report. 118
Motor complications of Parkinson's disease. 117
Pergolide compared with bromocriptine in Parkinson's disease: a multicenter,crossover, controlled study. 116
Premenstrual dysphoric disorder and eating disorders. 115
The influence of gender in the evaluation of platelet and plasma catecholamines. 115
Active music therapy in Parkinson's disease: an integrative method for motor and emotional rehabilitation. Psychosom Med. 2000 May-Jun;62(3):386-93. 115
Expression polymorphism of the blood-brain barrier component P-glycoprotein(MDR1) in relation to Parkinson's disease. 114
The autonomic nervous system and hypoxia: mountain medicine. 111
Plasma homocysteine and l-dopa metabolism in patients with Parkinson disease. 108
Hydroxyl radical production in the substantia nigra after 6-hydroxydopamine and hypoxia-reoxygenation. 108
Functional changes of the basal ganglia circuitry in Parkinson's disease. Prog Neurobiol. 2000 Sep;62(1):63-88. 103
Electrophysiological study on jaw-opening reflex recorded from digastric muscle in Parkinson's disease and primary cranial dystonias. 103
Terguride in stable Parkinson's disease. 99
ALTITUDE, EXERCISE, AND MOUNTAIN MEDICINE: LESSONS FROM THE FIELD. 98
CARDIOPRESSOR EFFECTS OF SHORT-TERM TREATMENT WITH CABERGOLINE IN L-DOPA STABLE RESPONDER PARKINSONIAN PATIENTS: RELEVANCE OF POSTPRANDIAL HYPOTENSION. 97
Active music therapy and Parkinson's disease: methods. 95
Gene-environment interaction in parkinson's disease. The case of CYP2D6 gene polymorphism. 93
LISURIDE AND BROMOCRYPTINE IN L-DOPA STABLE-RESPONDER PARKINSONIAN PATIENTS: A COMPARATIVE, DOUBLE-BLIND EVALUATION OF CARDIOPRESSOR AND NEUROCHEMICAL EFFECTS. 92
The effects of physical exercise at high altitude on adrenocortical function in humans. 89
Effects of dopaminergic stimulation on peripheral markers of apoptosis: relevance to Parkinson's disease 87
Autonomic disorders in Parkinson's disease. 85
Reproductive life milestones in women with Parkinson's disease. 85
Dihydroergocryptine in the treatment of Parkinson's disease: a six months' double-blind clinical trial. 83
COMT inhibition and safety. 79
Further characterization of autonomic involvement in multiple system atrophy: a pupillometric study. 78
Parkinson's Disease Comorbidity Study Group. Comorbid disorders and hospitalisation in Parkinson's disease: a prospective study. 75
Evidence of alpha-N-acetyl beta-endorphin in human cerebrospinal fluid. 74
Totale 9.352
Salva come PNG Salva come JPEG
Categoria #
all - tutte 28.717
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.717
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.231 0 0 0 0 126 170 208 234 153 127 38 175
2020/20211.280 42 143 63 145 82 145 49 101 186 49 109 166
2021/2022824 93 66 80 112 12 46 28 38 30 116 62 141
2022/20231.405 104 89 219 128 93 302 0 172 165 46 59 28
2023/20241.987 342 358 334 355 361 88 6 69 47 14 2 11
2024/2025320 2 31 245 31 11 0 0 0 0 0 0 0
Totale 9.352